These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 21576268

  • 1. Analysis of glycosaminoglycans in cerebrospinal fluid from patients with mucopolysaccharidoses by isotope-dilution ultra-performance liquid chromatography-tandem mass spectrometry.
    Zhang H, Young SP, Auray-Blais C, Orchard PJ, Tolar J, Millington DS.
    Clin Chem; 2011 Jul; 57(7):1005-12. PubMed ID: 21576268
    [Abstract] [Full Text] [Related]

  • 2. A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses.
    Zhang H, Wood T, Young SP, Millington DS.
    Mol Genet Metab; 2015 Feb; 114(2):123-8. PubMed ID: 25458519
    [Abstract] [Full Text] [Related]

  • 3. Quantification of Glycosaminoglycans in Urine by Isotope-Dilution Liquid Chromatography-Electrospray Ionization Tandem Mass Spectrometry.
    Zhang H, Young SP, Millington DS.
    Curr Protoc; 2023 Mar; 3(3):e701. PubMed ID: 36929617
    [Abstract] [Full Text] [Related]

  • 4. Quantification of glycosaminoglycans in urine by isotope-dilution liquid chromatography-electrospray ionization tandem mass spectrometry.
    Zhang H, Young SP, Millington DS.
    Curr Protoc Hum Genet; 2013 Mar; Chapter 17():Unit 17.12. PubMed ID: 23315926
    [Abstract] [Full Text] [Related]

  • 5. Comparison of dermatan sulfate and heparan sulfate concentrations in serum, cerebrospinal fluid and urine in patients with mucopolysaccharidosis type I receiving intravenous and intrathecal enzyme replacement therapy.
    Zhang H, Dickson PI, Stiles AR, Chen AH, Le SQ, McCaw P, Beasley J, Millington DS, Young SP.
    Clin Chim Acta; 2020 Sep; 508():179-184. PubMed ID: 32442432
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of cerebrospinal fluid heparan sulfate as a biomarker of neuropathology in a murine model of mucopolysaccharidosis type II using high-sensitivity LC/MS/MS.
    Tanaka N, Kida S, Kinoshita M, Morimoto H, Shibasaki T, Tachibana K, Yamamoto R.
    Mol Genet Metab; 2018 Sep; 125(1-2):53-58. PubMed ID: 30064964
    [Abstract] [Full Text] [Related]

  • 7. Newborn screening and diagnosis of mucopolysaccharidoses.
    Tomatsu S, Fujii T, Fukushi M, Oguma T, Shimada T, Maeda M, Kida K, Shibata Y, Futatsumori H, Montaño AM, Mason RW, Yamaguchi S, Suzuki Y, Orii T.
    Mol Genet Metab; 2013 Sep; 110(1-2):42-53. PubMed ID: 23860310
    [Abstract] [Full Text] [Related]

  • 8. A modified liquid chromatography/tandem mass spectrometry method for predominant disaccharide units of urinary glycosaminoglycans in patients with mucopolysaccharidoses.
    Chuang CK, Lin HY, Wang TJ, Tsai CC, Liu HL, Lin SP.
    Orphanet J Rare Dis; 2014 Sep 02; 9():135. PubMed ID: 25178307
    [Abstract] [Full Text] [Related]

  • 9. Efficient analysis of urinary glycosaminoglycans by LC-MS/MS in mucopolysaccharidoses type I, II and VI.
    Auray-Blais C, Bhérer P, Gagnon R, Young SP, Zhang HH, An Y, Clarke JT, Millington DS.
    Mol Genet Metab; 2011 Jan 02; 102(1):49-56. PubMed ID: 20934363
    [Abstract] [Full Text] [Related]

  • 10. Glycosaminoglycans in human cerebrospinal fluid determined by LC-MS/MS MRM.
    Yu Y, Zhang F, Colón W, Linhardt RJ, Xia K.
    Anal Biochem; 2019 Feb 15; 567():82-84. PubMed ID: 30571946
    [Abstract] [Full Text] [Related]

  • 11. Quantitative analysis of glycosaminoglycans, chondroitin/dermatan sulfate, hyaluronic acid, heparan sulfate, and keratan sulfate by liquid chromatography-electrospray ionization-tandem mass spectrometry.
    Osago H, Shibata T, Hara N, Kuwata S, Kono M, Uchio Y, Tsuchiya M.
    Anal Biochem; 2014 Dec 15; 467():62-74. PubMed ID: 25197028
    [Abstract] [Full Text] [Related]

  • 12. Characterization of Fluid Biomarkers Reveals Lysosome Dysfunction and Neurodegeneration in Neuronopathic MPS II Patients.
    Bhalla A, Ravi R, Fang M, Arguello A, Davis SS, Chiu CL, Blumenfeld JR, Nguyen HN, Earr TK, Wang J, Astarita G, Zhu Y, Fiore D, Scearce-Levie K, Diaz D, Cahan H, Troyer MD, Harris JM, Escolar ML.
    Int J Mol Sci; 2020 Jul 22; 21(15):. PubMed ID: 32707880
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Analytical method for the determination of disaccharides derived from keratan, heparan, and dermatan sulfates in human serum and plasma by high-performance liquid chromatography/turbo ionspray ionization tandem mass spectrometry.
    Oguma T, Tomatsu S, Montano AM, Okazaki O.
    Anal Biochem; 2007 Sep 01; 368(1):79-86. PubMed ID: 17603992
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. High-Throughput Liquid Chromatography-Tandem Mass Spectrometry Quantification of Glycosaminoglycans as Biomarkers of Mucopolysaccharidosis II.
    Wang J, Bhalla A, Ullman JC, Fang M, Ravi R, Arguello A, Thomsen E, Tsogtbaatar B, Guo JL, Skuja LL, Dugas JC, Davis SS, Poda SB, Gunasekaran K, Costanzo S, Sweeney ZK, Henry AG, Harris JM, Henne KR, Astarita G.
    Int J Mol Sci; 2020 Jul 30; 21(15):. PubMed ID: 32751752
    [Abstract] [Full Text] [Related]

  • 19. Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses.
    Kubaski F, Suzuki Y, Orii K, Giugliani R, Church HJ, Mason RW, Dũng VC, Ngoc CT, Yamaguchi S, Kobayashi H, Girisha KM, Fukao T, Orii T, Tomatsu S.
    Mol Genet Metab; 2017 Mar 30; 120(3):247-254. PubMed ID: 28065440
    [Abstract] [Full Text] [Related]

  • 20. Plasma and urinary levels of dermatan sulfate and heparan sulfate derived disaccharides after long-term enzyme replacement therapy (ERT) in MPS I: correlation with the timing of ERT and with total urinary excretion of glycosaminoglycans.
    de Ru MH, van der Tol L, van Vlies N, Bigger BW, Hollak CE, Ijlst L, Kulik W, van Lenthe H, Saif MA, Wagemans T, van der Wal WM, Wanders RJ, Wijburg FA.
    J Inherit Metab Dis; 2013 Mar 30; 36(2):247-55. PubMed ID: 22991166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.